-
4DMT Reports Positive 1-Year Efficacy for AAV Cystic Fibrosis Gene Therapy
Dec 17 2025 -
Genflow Biosciences Reports Strong Safety Profile After Completing Dosing of AAV SIRT6 Gene Therapy in Canine Clinical Trial
Dec 16 2025 -
AAV Gene Therapy Using AAV-Ant1 Successfully Restores Mitochondrial Function to Halt Dilated Cardiomyopathy in Mouse Models
Dec 16 2025 -
AAV Gene Therapy Successfully Restores Hearing in Hereditary Deafness Models Using Targeted GRE Expression
Dec 16 2025 -
Kyverna’s CAR-T Therapy Succeeds in Stiff Person Syndrome Trial and Targets First Autoimmune Approval
Dec 15 2025 -
Link Cell Therapies Launches with $60M Series A to Advance Logic-Gated CAR-T for Solid Tumors
Dec 15 2025 -
FDA Grants Orphan Drug Designation to Immusoft’s Engineered B Cell Therapy for the Treatment of MPS II
Dec 15 2025 -
CIRM Awarded $7.4 Million Grant to Advance Novel AAV Gene Therapy for Rare Muscular Dystrophy
Dec 15 2025 -
Moderna Partners with Nanexa to Develop Long-Acting Injectable mRNA Medicines
Dec 12 2025